ArticleJTO clinical and research reports2026

Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 Study.

Gustavo Schvartsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.